50 results match your criteria: "University Hospital Parma[Affiliation]"
Clin Cancer Res
December 2024
University of Parma, Parma, Italy.
Purpose: To uncover the underpinnings of acquired resistance (AR) to immunotherapy (IO), we determined whether distinctive clinico-pathological, radiomic and peripheral blood (PB) immune-inflammatory features reflect oligo- and systemic (sys)-AR in advanced NSCLC patients undergoing immune checkpoints inhibitors.
Experimental Design: On 105 consecutive IO-treated advanced NSCLC, PB immunophenotypes, cytokines and CT-derived radiomic features (RFs), extracted from primary and merged metastatic lesions, were prospectively collected at baseline (T0) and first disease assessment (T1, 9-12 weeks), and their delta (Δ) variation [(T1-T0)/T0] computed. AR, defined as progression after initial response (complete/partial) or stable disease ≥ 6 months, was subdivided according to the number of new and/or progressive lesions in oligoAR (≤3) and sysAR (>3).
J Clin Endocrinol Metab
December 2024
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Context: Subclinical thyroid dysfunction (ScTD) comprising subclinical hypothyroidism (SHypo) and subclinical hyperthyroidism (SHyper) has been associated with increased risk for cardiovascular events.
Objective: To assess associations between ScTD and cardiovascular risk factors (cvRFs) according to age and sex.
Design And Setting: Pooled individual participant data analysis of large prospective cohort studies from the Thyroid Studies Collaboration.
Eur Cardiol
November 2024
Division of Cardiology, University of Parma, Parma University Hospital Parma, Italy.
Eur J Obstet Gynecol Reprod Biol
January 2025
Department of Medicine and Surgery, University of Parma, PR, Italy; University Hospital Parma, PR, Italy.
Ann Surg Oncol
February 2025
General Surgery Unit, University Hospital Parma, Parma, Italy.
J Am Heart Assoc
November 2024
Center for Research on Cardiac Disease in Women, Department of Clinical Science University of Bergen Norway.
Front Med (Lausanne)
September 2024
Department of Nephrology, Christus Spohn Health System, Corpus Christi, TX, United States.
Pulmonology
September 2024
Department of Medical Specialities/Pulmonology Ospedale GB Morgagni, Forlì (I); DIMEC, Bologna University, Forlì Campus, Forlì I, Department; Department of Respiratory Diseases & Allergy, Aarhus University, Aarhus, Denmark.
Eur Urol Focus
March 2024
Department of Urology, Charité Universitätsmedizin, Berlin, Germany; Department of Urology, Medical University Vienna, Austria.
Cisplatin remains a valid option in muscle-invasive or metastatic urothelial carcinoma, and is even more efficient when nivolumab is added. The well-known side-effect profile and the limited number of treatment cycles represent great advantages over modern drug combinations such as enfortumab-vedotin plus pembrolizumab.
View Article and Find Full Text PDFEur Urol Oncol
October 2024
Oncology Unit, Macerata Hospital, Macerata, Italy.
Background And Objective: Papillary renal cell carcinoma (pRCC) is the most frequent histological subtype of non-clear cell RCC (nccRCC). Owing to the heterogeneity of nccRCC, patients are often excluded from large phase 3 trials focused on clear cell RCC, so treatment options for nccRCC remain limited. Our aim was to investigate the efficacy of first-line treatment with tyrosine kinase inhibitors (TKIs) or immuno-oncology (IO)-based combinations in patients with pRCC.
View Article and Find Full Text PDFRespir Res
January 2024
National Reference Center for Rare Pulmonary Diseases (OrphaLung), Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, Lyon, France.
Nephrol Dial Transplant
January 2024
Renal Research Institute, New York, NY, USA.
J Am Heart Assoc
August 2023
Division of Cardiology, "Città della Salute e della Scienza di Torino" Hospital, Department of Medical Sciences University of Turin Italy.
Background The impact of complete revascularization (CR) on the development of heart failure (HF) in patients with acute coronary syndrome and multivessel coronary artery disease undergoing percutaneous coronary intervention remains to be elucidated. Methods and Results Consecutive patients with acute coronary syndrome with multivessel coronary artery disease from the CORALYS (Incidence and Predictors of Heart Failure After Acute Coronary Syndrome) registry were included. Incidence of first hospitalization for HF or cardiovascular death was the primary end point.
View Article and Find Full Text PDFThe present study aimed to investigate the role of motivational process and coping resources in health professionals during the COVID-19 emergency examining the role of Care Unit Identification and safety climate perception as resources that can help nurses to cope with stressors. A cross-sectional research design was used and 218 nurses completed a self-report questionnaire measuring: Perception of safety, Care Unit identification, Work Engagement, Psychological Distress, and Burnout. Results revealed that Work Engagement was significantly related with Burnout ( = -0.
View Article and Find Full Text PDFActa Biomed
June 2022
Internal Medicine Unit, Department of Internal and Emergency Medicine. Parma University Hospital. Parma, Italy..
Vertebroplasty consists of injection under image guidance of a cement polymer, commonly polymethylmethacrylate, into the vertebral body to improved stability. Vertebroplasty is essentially safety. However whether vertebral compression or (micro)fractures occur during the procedure, the high vascularization and the anatomic network of the paravertebral and extradural venous plexuses, can facilitate migration of cement fragments into the systemic venous circulation.
View Article and Find Full Text PDFPlatypnea-Orthodeoxia Syndrome (POS) is a clinical entity defined as positional dyspnoea (platypnea) and arterial desaturation (orthodeoxia) that occurs when sitting or standing up and usually resolves by lying down. Up to April 25th 2021, eleven cases of POS after SARS-CoV-2 pneumonia have been reported on Pubmed. Accordingly, SARS-CoV-2 infection may be considered as an emergent cause of POS due to an increase in ventilation/perfusion (V/Q) mismatch.
View Article and Find Full Text PDFIntroduction: Acute supralevator abscess (SLA) is an uncommon and complicated form of anorectal sepsis. Its correct management is crucial to avoid complex iatrogenic fistula formation. A comprehensive review of the literature was conducted to determine the incidence of SLA and the surgical outcome with particular reference to the direction of drainage.
View Article and Find Full Text PDFActa Neurol Belg
December 2022
Child Neuropsychiatry Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Tech Coloproctol
December 2021
General Surgery Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
J Clin Med
August 2021
Cardiology Division, Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 20138 Milano, Italy.
Kidney Int
December 2021
FCRIN-INI-CRCT Network (French Clinical Research Infrastructure Network-Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists), Nancy, France; Centre Hospitalier F.H. Manhès, Fleury-Mérogis, France.
Lung congestion is a risk factor for all-cause and cardiovascular mortality in patients on chronic hemodialysis, and its estimation by ultrasound may be useful to guide ultrafiltration and drug therapy in this population. In an international, multi-center randomized controlled trial (NCT02310061) we investigated whether a lung ultrasound-guided treatment strategy improved a composite end point (all-cause death, non-fatal myocardial infarction, decompensated heart failure) vs usual care in patients receiving chronic hemodialysis with high cardiovascular risk. Patient-Reported Outcomes (Depression and the Standard Form 36 Quality of Life Questionnaire, SF36) were assessed as secondary outcomes.
View Article and Find Full Text PDFTech Coloproctol
April 2022
Emergency Radiology Unit, University Hospital Parma, Parma, Italy.
Nephrol Dial Transplant
December 2021
Department Internal Medicine, Division of Nephrology, Maastricht University Medical Center, Maastricht, The Netherlands.
Background: Patients on kidney replacement therapy (KRT) are at very high risk of coronavirus disease 2019 (COVID-19). The triage pathway for KRT patients presenting to hospitals with varying severity of COVID-19 illness remains ill-defined. We studied the clinical characteristics of patients at initial and subsequent hospital presentations and the impact on patient outcomes.
View Article and Find Full Text PDF